CVS Health
CVS
2,114 hedge funds and large institutions have $70B invested in CVS Health in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 780 increasing their positions, 1,020 reducing their positions, and 173 closing their positions.
29% more call options, than puts
Call options by funds: $1.7B | Put options by funds: $1.32B
19% more funds holding in top 10
Funds holding in top 10: 43 → 51 (+8)
2% more capital invested
Capital invested by funds: $68.9B → $70B (+$1.06B)
0.06% more ownership
Funds ownership: 77.84% → 77.9% (+0.06%)
4% less funds holding
Funds holding: 2,204 → 2,114 (-90)
24% less repeat investments, than reductions
Existing positions increased: 780 | Existing positions reduced: 1,020
36% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 173
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.42B |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$758M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$704M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$552M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$439M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$496M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$459M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$182M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$175M |
| 5 |
Morgan Stanley
New York
|
-$152M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
2276
Parallax Volatility Advisers
San Francisco,
California
| – | -$34K | -480 | Closed |
|
|
BFPW
2277
BOK Financial Private Wealth
Denver,
Colorado
| – | -$30.7K | -444 | Closed |
|
|
TVWM
2278
Tower View Wealth Management
Shorewood,
Wisconsin
| – | -$20K | -292 | Closed |
|
|
DMKJ
2279
David M. Knott Jr
| – | -$18K | -258 | Closed |
|
|
LFA
2280
Legend Financial Advisors
Pittsburgh,
Pennsylvania
| – | -$15.6K | -225 | Closed |
|
|
SF
2281
Safeguard Financial
Minocqua,
Wisconsin
| – | -$13K | -200 | Closed |
|
|
MIM
2282
Macroview Investment Management
Bethesda,
Maryland
| – | -$7.36K | -106 | Closed |
|
|
EP
2283
Elkhorn Partners
Omaha,
Nebraska
| – | -$7K | -100 | Closed |
|
|
DI
2284
Disciplined Investments
Tulsa,
Oklahoma
| – | -$5.32K | -77 | Closed |
|
|
KHC
2285
Koesten Hirschmann & Crabtree
Overland Park,
Kansas
| – | -$4.15K | -60 | Closed |
|
|
SHIM
2286
Stone House Investment Management
Tunkhannock,
Pennsylvania
| – | -$1.81K | -26 | Closed |
|
|
CWA
2287
Clearview Wealth Advisors
Salem,
Oregon
| – | -$1.04K | -15 | Closed |
|
CVS Hedge Fund Activity: Q3 2023 in Review
2,114 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2023, worth a combined $70B — up 1.5% from $68.9B a quarter earlier.
Sellers outnumbered buyers: 173 funds closed out of CVS and 111 opened new positions — a net loss of 62 holders — while 1,020 trimmed existing stakes and 780 added.
The largest buyer was Capital International Investors, adding an estimated $1.42B. The largest seller was BlackRock, cutting an estimated $496M.
- 2,114 institutional investors held CVS Health (CVS) as of Q3 2023, down from 2,204 in Q2 2023.
- Funds reported $70B of CVS Health stock for Q3 2023, up 1.5% quarter-over-quarter.
- 111 funds opened new CVS Health positions in Q3 2023 and 173 closed out, a net change of -62 holders.
- The largest CVS Health buyer in Q3 2023 was Capital International Investors, an estimated $1.42B added.
- The largest CVS Health seller in Q3 2023 was BlackRock, an estimated $496M sold.
Based on aggregated 13F filings for Q3 2023.